As of 2024-12-11, the EV/EBITDA ratio of Clinigen Group PLC (CLIN.L) is
3.79.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLIN.L's latest enterprise value
is 1,527.24 mil GBP. CLIN.L's TTM EBITDA according to its financial statements is
402.90 mil GBP. Dividing these 2
quantities gives us the above CLIN.L EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
8.2x - 21.0x |
13.2x |
| Forward P/E multiples |
12.9x - 17.1x |
16.0x |
| Fair Price |
736.68 - 6,126.36 |
2,369.64 |
| Upside |
-20.4% - 562.3% |
156.2% |